Increased circulating intercellular adhesion molecule-1 levels in type II diabetic patients: the possible role of metabolic control and oxidative stress

Metabolism: Clinical and Experimental
A CerielloE Bartoli

Abstract

Blood levels of the circulating form of the integrin intercellular adhesion molecule-1 (ICAM-1), malondialdehyde (MDA), and hemoglobin A1c (HbA1c) were studied at baseline and 3 months after improved metabolic control in 25 type II diabetic patients without signs of macroangiopathy, and were compared with those in 15 matched healthy normal controls. Circulating ICAM-1 and MDA levels were increased in diabetic patients, both at baseline and 3 months later. However, with improving metabolic control HbA1c, circulating ICAM-1, and MDA significantly decreased. A significant correlation between circulating ICAM-1, HbA1c, and MDA was found in diabetic patients at each time. Multiple regression analysis considering circulating ICAM-1 as the dependent variable and HbA1c and MDA as independent variables, showed a significant correlation between the three variable at each time. Similar correlations were found in control subjects. These data show increased levels of circulating ICAM-1 in type II diabetic patients, independent of the presence of macroangiopathy. Moreover, these results suggest that oxidative stress and metabolic control might participate in determining increased circulating ICAM-1 levels in both type II diabetic patients an...Continue Reading

Citations

Oct 3, 2002·Diabetic Medicine : a Journal of the British Diabetic Association·K MatsumotoS Miyake
May 16, 2002·Clinical and Experimental Pharmacology & Physiology·Hiroyuki ItoKazuo Nishioka
Jun 21, 2005·International Journal of Clinical Practice·G I VarugheseG Y H Lip
Oct 14, 2003·Arteriosclerosis, Thrombosis, and Vascular Biology·Frank B Hu, Meir J Stampfer
Aug 22, 2007·Cell Biochemistry and Biophysics·R RobertsonJamie S Harmon
May 23, 1998·Arteriosclerosis, Thrombosis, and Vascular Biology·Y AbeC M Ballantyne
Apr 20, 2001·Journal of Pediatric Endocrinology & Metabolism : JPEM·N DoğruelT Us
Mar 10, 2001·The Journal of Clinical Endocrinology and Metabolism·G CeolottoA Avogaro
Oct 28, 2004·Biochemical Society Transactions·C M WilliamsK G Jackson
Aug 4, 2005·Scandinavian Journal of Clinical and Laboratory Investigation·M TrøseidI Seljeflot
Nov 2, 2012·Nutrition & Metabolism·Caroline Isoppo de SouzaMarcia Silveira Graudenz
Jul 6, 2016·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Márta KaszaV Nagy
Jun 2, 2017·European Journal of Applied Physiology·Monique E Francois, Jonathan P Little
Feb 25, 2019·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·Wensheng MiYanhui Bian
Oct 16, 1999·The Journal of Clinical Endocrinology and Metabolism·N G ChenG M Reaven
Jun 15, 2007·Current Opinion in Clinical Nutrition and Metabolic Care·Philip C CalderPhilip Newsholme
Jun 25, 2005·Diabetic Medicine : a Journal of the British Diabetic Association·V R SørensenB Feldt-Rasmussen
Oct 9, 2020·Yeungnam University Journal of Medicine·Soyoung Park, So-Young Park
May 2, 2002·Clinica Chimica Acta; International Journal of Clinical Chemistry·Giovambattista DesideriClaudio Ferri
Jul 29, 1998·Free Radical Biology & Medicine·I GrattaglianoE Altomare

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.